Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00913484 · ClinicalTrials.gov registry record · Phase 2
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 177
- Enrollment target
NCT00913484 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 177 participants.
The verdict
NCT00913484, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 177 participants
- Enrollment target
Study Summary
The investigators are proposing a placebo-controlled clinical trial to evaluate the efficacy and potential mechanisms of action of disulfiram (versus placebo) for treating cocaine abuse in subjects with concurrent opiate dependence and cocaine abuse or dependence maintained on buprenorphine/naloxone combination.
Interventions
- DRUG Placebo
- DRUG Disulfiram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2000-10 |
| Est. Completion | 2004-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00913484
The ClinicalTrials.gov registry entry for NCT00913484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00913484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00913484 about?
NCT00913484 is a clinical study titled "Disulfiram for Cocaine Abuse in Buprenorphine Treatment". The investigators are proposing a placebo-controlled clinical trial to evaluate the efficacy and potential mechanisms of action of disulfiram (versus placebo) for treating cocaine abuse in subjects with concurrent opiate dependence and cocaine abuse or dependence maintained on buprenorphine/naloxone...
What is the current status of trial NCT00913484?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 177 participants. The study started on 2000-10. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00913484?
The interventions under investigation include: Placebo (DRUG), Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00913484?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.